Redeye initiates coverage of Ortoma, a Swedish medtech company in early stage commercialisation with its Ortoma Treatment Solution (OTS™), helping surgeons to preplan, navigate, and follow up on orthopaedic implant and prosthesis surgeries. Ortoma has established a strategic partnership with Johnson & Johnson K.K (J&J) in Japan and is negotiating a global distribution partnership (excluding Japan) with DePuy Synthes.

Read more and download the Research Report.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Ortoma - Preplanning for success

© Modular Finance, source Nordic Press Releases